https://www.selleckchem.com/EGFR(HER).html
There were no complications and no ablated patient developed postprocedure recurrent laryngeal nerve dysfunction. All 17 ablated tumors shrank (median 93%) and Doppler flow eliminated. Median tumor volume reduction in 9 identifiable avascular foci was 82% (range, 26%-93%). After EA, 8 tumors (47%) disappeared on sonography after a median of 10 months. During follow-up no new PTM foci and no nodal metastases have been identified. Definitive treatment of APTM by EA is effective, safe, and inexpensive. Our results suggest that, for APTM patients
Like
Comment
Share
